Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group - Wikidata - awgldk - TriplyDB

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

http://www.wikidata.org/entity/Q28247583

about

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy Cyclosporin-induced flushing in a renal transplant recipient resolving after substitution with tacrolimus Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury.Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection Cardiac allograft vasculopathy: current knowledge and future direction.Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort Management of ANCA-associated vasculitis: Current trends and future prospects Immunosuppression for lung transplantation.Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned.The metabolic effects of cyclosporin and tacrolimus.Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.Current treatment practice in immunosuppression.Long-term results of pancreas transplantation under tacrolius immunosuppression.Tacrolimus for rescue of refractory renal allograft rejection New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT.Prophylaxis and treatment of gastrointestinal complications following transplantation.Sirolimus is associated with new-onset diabetes in kidney transplant recipients.Immune profiling and cancer post transplantation New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.Novel views on new-onset diabetes after transplantation: development, prevention and treatment.Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicity New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients.Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation.Renal transplantation, immunosuppression and the skin: an update.Posttransplant Hyponatremia Predicts Graft Failure and Mortality in Kidney Transplantation Recipients: A Multicenter Cohort Study in Korea.Protocol biopsies after kidney transplantation.Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients.Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.

P2860

Q24245456-B70D9413-2EF4-48CD-927F-5B0934F91F00 Q24595480-831FFFC9-DF4B-4B95-AAAB-664B99EFA5E4 Q24799540-0F6A6133-32D9-4850-993A-59F42D8A20A6 Q26795773-10AFA0C3-C5C4-4BA1-BA68-251C84191B59 Q28175580-E5C7EE0A-9F29-4BA8-A7D0-DA691E8F025C Q28346573-91B5B837-7F9C-4297-9FF2-344D75D3BB79 Q28374069-6A9E6A30-789A-4772-B367-9998E011436F Q28378195-C89E6AB7-2058-49EE-BEF2-A98F091CB4EF Q28539334-96E126D8-8AE2-4983-948A-844FA03FE08A Q28551398-A6B043C5-12D8-4AF7-8E14-397943B59E47 Q30583015-058C6C00-5EAD-418F-9641-3DDF60E0A6CE Q31004418-2E129BA7-B347-4B46-A226-C34A00B0541B Q31617397-C13A16F6-83F0-4D0B-8C1E-EB77C933A5BD Q33670571-191AFA5D-3FE0-470D-A5BD-24B799D1831F Q33694700-9FB3B24E-E483-43BD-8C13-93EABBC517D1 Q33860323-F7C9DE1C-7DDC-44F7-8C01-D75D7CA5D641 Q33880261-81E6AE24-2535-4F7A-9043-87EBEEB92C02 Q33947599-7B8769F9-DACF-4550-8C9B-A49C34599C31 Q33996931-85883E38-D4F7-40EA-8A8D-DC5894BA8C70 Q34025909-607D8460-AFE1-414E-B247-FB5E62F1B09C Q34045311-D9B41E6D-C7EB-45D0-9172-35E1E45E96AB Q34076610-65398415-3DAE-4BC6-AE73-098F3787A609 Q34181796-502EEFDC-C1A3-4BEB-9021-B9678F9ABA51 Q34302128-D1C29C37-1F14-412F-A58E-476A4BF454BE Q34318175-96C452E6-8B4F-48F7-BF2A-2F8BC0A1B898 Q34368857-37113E9B-6AC9-469E-884E-70D4143A26F4 Q34485493-45FE4180-CE0A-4D2C-9B6A-6165DDDA4786 Q34767143-7FFEE482-8C63-480C-A9BA-533A6CF703E1 Q35050810-AC897CA7-D1E3-469A-A07C-2CC640CCF17C Q35153309-CD41A723-C649-47FB-82D3-B75409BFA0AC Q35221336-8E69DBF4-1658-436D-A32E-5C6039C89052 Q35385844-39B57711-5D98-481D-96CE-38296AB89D5E Q35691924-434E24C7-79F6-449B-88A6-490EDE5CAE0A Q35827212-4716A2E4-2C2B-4558-800C-A9861A5D14BD Q35993866-01A145B1-C183-4B1A-895C-D8A90F25289C Q36000874-0507EEBF-E2CB-4F21-A5E9-B50487B66703 Q36026649-18CA93F3-0E2B-44CC-A525-0381CE75D749 Q36029862-81D363A0-44C4-4B80-A037-86A52F36CAB0 Q36053737-87C922D9-023D-45E6-A732-20E2FBCDB835 Q36073213-5A7295EB-A417-468F-9DED-246ADABBD7CC

P2860

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

http://www.wikidata.org/entity/Q28247583

description

1997 nî lūn-bûn

@nan

1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Multicenter randomized trial c ...... Multicenter Renal Study Group

@ast

Multicenter randomized trial c ...... Multicenter Renal Study Group

@en

Multicenter randomized trial c ...... Multicenter Renal Study Group

@nl

type

label

Multicenter randomized trial c ...... Multicenter Renal Study Group

@ast

Multicenter randomized trial c ...... Multicenter Renal Study Group

@en

Multicenter randomized trial c ...... Multicenter Renal Study Group

@nl

prefLabel

Multicenter randomized trial c ...... Multicenter Renal Study Group

@ast

Multicenter randomized trial c ...... Multicenter Renal Study Group

@en

Multicenter randomized trial c ...... Multicenter Renal Study Group

@nl

P1433

Q28247583-FCB69A54-77BC-4B6A-8FAD-DBDDAA4F5996

P1476

Q28247583-3DE82571-C55E-48AF-86AA-68E4BFAEA8AD

P2093

Q28247583-13C30E44-7DFC-43E1-B0DB-2D596AB180AD

Q28247583-17196422-078C-4952-B6E9-CA86E9F2F06F

Q28247583-1CF66CF7-FB29-45A0-A447-F11A97AC6ECA

Q28247583-2C55F112-3B2E-4026-B688-B27DF4050535

Q28247583-2FF105F5-CACE-4E62-8459-7F3C95DC63E5

Q28247583-36B7790F-7999-4763-8CB6-7C74B792C5E6

Q28247583-3B0B2046-BAA7-4641-9CF2-599160F31AF2

Q28247583-4B7E0EEC-2E45-4EBE-B3A3-87E451AEE9F4

Q28247583-5300A3A1-F5CC-41B1-B30F-D8715D349D49

Q28247583-540B9684-4C6B-408B-AB29-BD0C4B3E55AB

P304

Q28247583-A3446DA6-73DA-4E21-8EE4-B2BA1153CC74

P31

Q28247583-8643FCD4-D7FC-4D23-AB60-165A979CF49D

P3181

Q28247583-168D7C1B-D522-4E51-8ED6-015C297AB000

P356

Q28247583-CD6ECC76-3CF6-4655-85EF-0C9D215FA0F4

P407

Q28247583-F7CDA209-A57B-47F9-BCAE-47063FEC0CDD

P433

Q28247583-F38068F5-B871-4E88-AF90-F613790B1552

P478

Q28247583-71D0A44D-471C-4A63-B3B5-CB040218F635

P50

Q28247583-3AED77FD-74F7-4C5E-92EC-0EAFA2B3D7EC

P577

Q28247583-31B42BB2-F819-4669-9487-B0AC1ACC6697

P698

Q28247583-85F6B70B-6442-4FFC-8AF8-CE50CC01D222

P921

Q28247583-41EB9E31-4613-43AF-BB58-CA2F93993CE4

P3181

P356

00007890-199708150-00012

P1433

Transplantation

P1476

Multicenter randomized trial c ...... Multicenter Renal Study Group

@en

P2093

A Andres

http://www.w3.org/2001/XMLSchema#string

A D Mayer

http://www.w3.org/2001/XMLSchema#string

B Buchholz

http://www.w3.org/2001/XMLSchema#string

B Grabensee

http://www.w3.org/2001/XMLSchema#string

B Klein

http://www.w3.org/2001/XMLSchema#string

C Short

http://www.w3.org/2001/XMLSchema#string

D Talbot

http://www.w3.org/2001/XMLSchema#string

E Pohanka

http://www.w3.org/2001/XMLSchema#string

F W Eigler

http://www.w3.org/2001/XMLSchema#string

J Dmitrewski

http://www.w3.org/2001/XMLSchema#string

P304

436-443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1434840

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/00007890-199708150-00012

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9275110

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial